Home Title

Transforming lives by breaking new ground in immunology treatment through specialist expertise

Transforming lives by breaking new ground in immunology treatment through specialist expertise

Transforming lives by breaking new ground in immunology treatment through specialist expertise.

Information on our 2022 AGM

AGM information
£72.8m Revenue (2021: £84.3m)
£3.4m Operating profit excluding R&D (2021: £16.9m)
£(13.8)m Net loss after tax (2021: net profit £2.9m)

Our year in numbers

Annual Report 2022

Take your career to new heights

Career Vacancies